CYP3A5 expressors had a numerically higher BMI (28.1 vs. 27.1; p = 0.10) and a numerically higher prevalence of prior stroke or TIA (4.1% vs. 2.2%; p = 0.10). This evidence concerns the gene CYP3A5 and stroke disorder.